Loading…
Loading…
AXQ Capital LP grew its stake in shares of Doximity, Inc. (NYSE: DOCS) by 1,354.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 177,044 shares of the company's stock after buying an additional 164,872 shares during the period. AXQ
On August 28, 2026, Doximity Inc (DOCS) shares rose 4.5% to a current price of $26.73. This performance occurred amidst a 52-week range of $17.15 to $76.51, ind
On August 27, 2026, Doximity Inc (DOCS) shares rose 3.4% to a current price of $25.59, reflecting a significant shift amidst a 52-week range of $17.15 to $76.51
MedPeer,Inc. (OTCMKTS:MDPEF - Get Free Report) and Doximity (NYSE: DOCS - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, dividends and analyst recommendations. Earnings and Valuation This table compares MedPeer,Inc. and Doximity"s gross
[url="]Doximity[/url], Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced new data indicating that physicians are f
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced new data indicating that physicians are finding an unexpected source of optimism in AI. Rather than viewing the technology as a threat, nearly a quarter expect it to increase their total compensation within the next year, and two-thirds believe staying current with AI will give them a meaningful earnings edge over peers who don't. The findings are part of Dox.
DOCS' AI expansion is opening new growth avenues, but rising AI costs and tight pharma budgets could temper near-term gains.
This sale was executed under a pre-established Rule 10b5-1 trading plan adopted in February.